Patients with an increase in claudin-2 expression lived for an average of 12 months without recurrence, in contrast to patients with approximately the same expression of claudin-2 in healthy and in tumor tissue of the oral cavity, who were free of recurrence, on average, for 34 months. This evidence concerns the gene CLDN2 and neoplasm.